Replies to post #6579 on AEterna Zentaris Inc. (AEZS)

[alexander77]

Wait here! There are no phase 3 results next month, the second leg of the DSMB evaluation about the ZopTEC phase 3 trial, regarding safety AND efficacy, will happen in October. This evaluation has three options:
1, stop the trial due to lack of efficacy
2, continue the trial because safety and efficacy look promissing, this will give more credibility to the company
3. Advice for immediate FDA approval due to superior safety and efficacy